ArticleHaematologica2022
Daratumumab for treatment-refractory acquired idiopathic pure red cell aplasia.
Naseema Gangat et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this paperpooled itcites it
ArticleHaematologica2022
Naseema Gangat et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.